Global Biobanking Market to reach USD 11.40 billion by 2027

Global Biobanking Market Size study, By Specimen Type (Blood Products, Solid Tissue, Nucleic Acid, and Cell Lines, Others), Type of Biobank (Population-based Biobanks and Disease-oriented Biobanks), Ownership (National/Regional Agencies, Nonprofit Organization, University, and Private Organization), and Application (Therapeutic and Research), and Regional Forecasts 2020-2027
Product Code:  HALB_35872616
Chapter 1.	Executive Summary 
1.1.	Market Snapshot
1.2.	Global & Segmental Market Estimates & Forecasts, 2018-2027 (USD Billion)
1.2.1.	Biobanking Market, by Region, 2018-2027 (USD Billion)
1.2.2.	Biobanking Market, by Specimen Type, 2018-2027 (USD Billion)
1.2.3.	Biobanking Market, by Type of Biobank, 2018-2027 (USD Billion)
1.2.4.	Biobanking Market, by Application, 2018-2027 (USD Billion)
1.2.5.	Biobanking Market, by Ownership, 2018-2027 (USD Billion)
1.3.	Key Trends
1.4.	Estimation Methodology
1.5.	Research Assumption
Chapter 2.	Global Biobanking Market Definition & Scope 
2.1.	Objective of the Study
2.2.	Market Definition & Scope
2.2.1.	Scope of the Study
2.2.2.	Industry Evolution
2.3.	Years Considered for the Study
2.4.	Currency Conversion Rates
Chapter 3.	Global Biobanking Market Dynamics	
3.1.	 Biobanking Market Impact Analysis (2018-2027)
3.1.1.	Market Drivers
3.1.2.	Market Challenges
3.1.3.	Market Opportunities
Chapter 4.	Global Biobanking Market: Industry Analysis
4.1.	Porter’s 5 Force Model
4.1.1.	Bargaining Power of Suppliers
4.1.2.	Bargaining Power of Buyers
4.1.3.	Threat of New Entrants
4.1.4.	Threat of Substitutes
4.1.5.	Competitive Rivalry
4.1.6.	Futuristic Approach to Porter’s 5 Force Model (2017-2027)
4.2.	PEST Analysis
4.2.1.	Political 
4.2.2.	Economical
4.2.3.	Social 
4.2.4.	Technological 
4.3.	Investment Adoption Model
4.4.	Analyst Recommendation & Conclusion
Chapter 5.	Global Biobanking Market, by Specimen Type 
5.1.	Market Snapshot 
5.2.	Global Biobanking Market by Specimen Type, Performance - Potential Analysis
5.3.	Global Biobanking Market Estimates & Forecasts by Specimen Type, 2017-2027 (USD Billion)
5.4.	 Biobanking Market, Sub Segment Analysis
5.4.1.	Blood Products
5.4.2.	Solid Tissue
5.4.3.	Cell Lines
5.4.4.	Nucleic Acid
5.4.5.	Others
Chapter 6.	Global Biobanking Market, by Type of Biobank 
6.1.	Market Snapshot 
6.2.	Global Biobanking Market by Type of Biobank, Performance - Potential Analysis
6.3.	Global Biobanking Market Estimates & Forecasts by Type of Biobank, 2017-2027 (USD Billion)
6.3.1.	Population-based Biobanks
6.3.2.	Disease-oriented Biobanks
Chapter 7.	Global Biobanking Market, by Application 
7.1.	Market Snapshot 
7.2.	Global Biobanking Market by Application, Performance - Potential Analysis
7.3.	Global Biobanking Market Estimates & Forecasts by Application, 2017-2027 (USD Billion)
7.3.1.	Therapeutic
7.3.2.	Research
Chapter 8.	Global Biobanking Market, by Ownership 
8.1.	Market Snapshot 
8.2.	Global Biobanking Market by Ownership, Performance - Potential Analysis
8.3.	Global Biobanking Market Estimates & Forecasts by Ownership, 2017-2027 (USD Billion)
8.3.1.	National/Regional Agencies
8.3.2.	Non-profit Organization
8.3.3.	University
8.3.4.	Private Organization
Chapter 9.	Global Biobanking Market, Regional Analysis
9.1.	 Biobanking Market, Regional Market Snapshot 
9.2.	North America Biobanking Market 
9.2.1.	U.S.  Biobanking Market
9.2.1.1.	Specimen Type breakdown estimates & forecasts, 2017-2027
9.2.1.2.	Type of Biobank breakdown estimates & forecasts, 2017-2027
9.2.1.3.	Application breakdown estimates & forecasts, 2017-2027
9.2.1.4.	Ownership breakdown estimates & forecasts, 2017-2027
9.2.2.	Canada Biobanking Market
9.3.	Europe Biobanking Market Snapshot
9.3.1.	U.K.  Biobanking Market 
9.3.2.	Germany Biobanking Market
9.3.3.	France Biobanking Market
9.3.4.	Spain Biobanking Market
9.3.5.	Italy Biobanking Market
9.3.6.	Rest of Europe Biobanking Market
9.4.	Asia-Pacific Biobanking Market Snapshot
9.4.1.	China Biobanking Market 
9.4.2.	India Biobanking Market 
9.4.3.	Japan Biobanking Market
9.4.4.	Australia Biobanking Market
9.4.5.	South Korea Biobanking Market
9.4.6.	Rest of Asia Pacific Biobanking Market
9.5.	Latin America Biobanking Market Snapshot
9.5.1.	Brazil Biobanking Market
9.5.2.	Mexico Biobanking Market
9.6.	Rest of The World Biobanking Market

Chapter 10.	Competitive Intelligence
10.1.	Top Market Strategies
10.2.	Company Profiles
10.2.1.	Thermo Fisher Scientific Inc.
10.2.1.1.	Key Information
10.2.1.2.	Overview
10.2.1.3.	Financial (Subject to Data Availability)
10.2.1.4.	Industry Summary
10.2.1.5.	Recent Developments
10.2.2.	Panasonic Healthcare Holdings Co., Ltd.
10.2.3.	Becton, Dickinson and Company
10.2.4.	Qiagen N.V.
10.2.5.	Merck KGaA
10.2.6.	VWR Corporation
10.2.7.	Tecan Trading AG
10.2.8.	Brooks Automation, Inc.
10.2.9.	Chart Industries, Inc.
10.2.10.	Hamilton Company
10.2.11.	Greiner Holding AG
10.2.12.	Promega Corporation
Chapter 11.	Research Process
11.1.	Research Process
11.1.1.	Data Mining
11.1.2.	Analysis
11.1.3.	Market Estimation
11.1.4.	Validation
11.1.5.	Publishing
11.2.	Research Attributes
11.3.	Research Assumption

Global Biobanking Market is valued approximately at USD 2.08 billion in 2019 and is anticipated to grow with a healthy growth rate of more than 23.7% over the forecast period 2020-2027. Biobanking is a method for gathering and storing biological resources that can be further used for diagnostics, ecosystem studies and analysis. Significant factors driving the growth of the global biobanking industry include expanded financial support from private and government organizations. In addition, an improvement in the prevalence of chronic diseases is driving demand growth. However, ethical and regulatory concerns related to biobanking are restricting business expansion. The emergence of the COVID-19 pandemic has taken the relevance of biobanks across the globe to the forefront. As a result, the rapid establishment of the COVID-19 biobank worldwide has witnessed the prospective selection of research biospecimens and the related clinical and patient data generated by COVID-19 patients with reported infection with the novel SARS-CoV-2 virus to allow high-quality research. For example, NHRI Biobank, Minister of Health and Welfare, was assigned to create a COVID-19 biobank at the beginning of February 2020 to collect blood samples of COVID-19 patients in an evolving way for Taiwanese researchers and industry. Both aspects are projected to have an impact on the biobanking industry in the future. The outbreak of the pandemic has also had a positive impact on the expansion of the biobanking market. Several chronic illnesses, such as cancer, cardiovascular disease, neurological disorders and immunological disorders, cannot be treated with traditional treatment due to adverse side effects. The risk of these side effects may be minimized by incorporating it into stem cell therapy, which serves as a curing agent to mitigate the harm caused by treatment doses. According to figures from the National Cancer Center, about 9.5 million people were confirmed to have cancer in the U.S. in 2019, and this figure is projected to rise to 19 million in 2024. Hence, the demand for cord blood for medicinal purposes, stimulating the development of the biobanking market.
The regional analysis of global Biobanking Market is considered for the key regions such as Asia Pacific, North America, Europe, Latin America, and Rest of the World. Asia-Pacific offers attractive prospects for major players operating in the biobanking industry due to a growth in population and the presence of a large geriatric population base. In addition, the increase in health spending and the developing guidlines are expected to fuel demand growth in the country.
Major market player included in this report are:
Thermo Fisher Scientific Inc.
Panasonic Healthcare Holdings Co., Ltd.
Becton, Dickinson and Company
Qiagen N.V.
Merck KGaA
VWR Corporation
Tecan Trading AG
Brooks Automation, Inc.
Chart Industries, Inc.
Hamilton Company
Greiner Holding AG
Promega Corporation

The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values to the coming eight years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within each of the regions and countries involved in the study. Furthermore, the report also caters the detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, the report shall also incorporate available opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and product offerings of key players. The detailed segments and sub-segment of the market are explained below:
By Specimen Type:
Blood Products
Solid Tissue
Cell Lines
Nucleic Acid
Others
By Type of Biobank:
Population-based Biobanks
Disease-oriented Biobanks
By Application:
Therapeutic
Research
By Ownership:
National/Regional Agencies
Non-profit Organization
University
Private Organization
By Region:
North America
U.S.
Canada
Europe
UK
Germany
France
Spain
Italy
ROE

Asia Pacific
China
India
Japan
Australia
South Korea
RoAPAC
Latin America
Brazil
Mexico
Rest of the World

Furthermore, years considered for the study are as follows:

Historical year – 2017, 2018
Base year – 2019
Forecast period – 2020 to 2027

Target Audience of the Global Biobanking Market in Market Study:

Key Consulting Companies & Advisors
Large, medium-sized, and small enterprises
Venture capitalists
Value-Added Resellers (VARs)
Third-party knowledge providers
Investment bankers
Investors


We offer 10% free customization including country-level data, niche applications and competitive landscape with every report. This also includes a 30 minute free analyst discussion post report purchase.

Full Name*

Business Email* (Please avoid generic email IDs such as gmail, yahoo)

Phone* (Please Affix Country Code)

Need specific market information? To get a customized report, please share your exact research requirements.



Loading…